Quality You Can Rely On

USDA‑Licensed Manufacturing

Kemin Biologics North America operates a USDA‑licensed manufacturing facility subject to oversight by the USDA Center for Veterinary Biologics (CVB). Manufacturing activities are conducted in alignment with applicable federal regulations governing autogenous veterinary biologics.

Autogenous‑Specific Production Controls and Documentation

Manufacturing of autogenous vaccines follows production controls and documentation requirements specific to autogenous products. Documentation is maintained to support regulatory expectations related to manufacturing activities and lot identification.

Safety and Sterility Testing

Safety and sterility testing are completed prior to product release, as required by regulation. Autogenous vaccines are not released until required testing activities have been completed.

Traceability

Documentation and control procedures support traceability throughout the manufacturing process for autogenous vaccines. These records align with regulatory expectations for autogenous product manufacturing.

Autogenous Vaccine Manufacturing Inquiries

For questions related to manufacturing or regulatory oversight, fill out the form below and a member of our team will be in contact with you shortly.